Katsuyoshi Chiba Selected Research

Katsuyoshi Chiba Research Topics

3	Cardiac Arrhythmias (Arrythmia) 01/2021 - 05/2018
3	Torsades de Pointes (Torsade de Pointes) 01/2021 - 02/2004
2	Cardiotoxicity 01/2022 - 05/2020
2	Necrosis 05/2020 - 01/2020
2	Stroke (Strokes) 01/2018 - 03/2017
2	Long QT Syndrome 01/2006 - 02/2004
2	Atrioventricular Block 05/2004 - 02/2004
1	Neoplasms (Cancer) 01/2022
1	Heart Failure 01/2022
1	Wounds and Injuries (Trauma) 05/2020
1	Hemorrhage 05/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 12/2018
1	Hypoglycemia (Reactive Hypoglycemia) 05/2018
1	Hyperglycemia 05/2018
1	Tachycardia (Tachyarrhythmias) 03/2017
1	Hypokalemia 01/2006
1	Bradycardia 05/2004

7	Pharmaceutical PreparationsIBA 01/2022 - 05/2004
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2004
3	Halothane (Fluothane)FDA Link 10/2004 - 02/2004
2	Milrinone (Primacor)FDA LinkGeneric 05/2020 - 03/2017
2	nifekalantIBA 02/2019 - 05/2004
2	sparfloxacin (AT 4140)FDA Link 01/2006 - 10/2004
1	Monoclonal AntibodiesIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Amino Acids FDA Link 05/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	firuglipelIBA 12/2018
1	Nicorandil (SG 75)IBA 01/2018
1	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 03/2017
1	Methoxamine (Methoxamine Hydrochloride)FDA Link 02/2004
1	sitafloxacinIBA 02/2004
1	ChloraloseIBA 02/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2004
1	FluoroquinolonesIBA 02/2004
1	Gatifloxacin (Zymar)FDA Link 02/2004
1	Moxifloxacin (Avelox)FDA Link 02/2004

1	Oral Administration 02/2004